These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35927904)

  • 1. A Systematic Review and Meta-Analysis on the Effect of Flavonoids on Insulin-like Growth Factor and Insulin-like Growth Factor Binding Protein and Incidence of Breast Cancer.
    Nasr S; Nakisa A; Jandaghian S; Kouhi M; Sadeghi E; Varshosaz J
    Curr Med Chem; 2023; 30(14):1657-1666. PubMed ID: 35927904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer.
    Pazaitou-Panayiotou K; Kelesidis T; Kelesidis I; Kaprara A; Blakeman J; Vainas I; Mpousoulegas A; Williams CJ; Mantzoros C
    Eur J Endocrinol; 2007 Feb; 156(2):187-94. PubMed ID: 17287408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis.
    Gong Y; Zhang B; Liao Y; Tang Y; Mai C; Chen T; Tang H
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28420208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of fruits, vegetables and flavonoids from fruits and vegetables during early life, mid-childhood and adolescence for levels of insulin-like growth factor (IGF-1) and its binding proteins IGFBP-2 and IGFBP-3 in young adulthood.
    Krupp D; Remer T; Penczynski KJ; Bolzenius K; Wudy SA; Buyken AE
    Br J Nutr; 2016 Feb; 115(3):527-37. PubMed ID: 26628272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin-like growth factor system is modulated by exercise in breast cancer survivors: a systematic review and meta-analysis.
    Meneses-Echávez JF; Jiménez EG; Río-Valle JS; Correa-Bautista JE; Izquierdo M; Ramírez-Vélez R
    BMC Cancer; 2016 Aug; 16(1):682. PubMed ID: 27562357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, Pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients.
    Helle SI; Anker GB; Tally M; Hall K; Lønning PE
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):167-71. PubMed ID: 8645625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of circulating insulin-like growth factor-I and binding proteins 1-7 with mammographic density among women undergoing image-guided diagnostic breast biopsy.
    Hada M; Oh H; Pfeiffer RM; Falk RT; Fan S; Mullooly M; Pollak M; Geller B; Vacek PM; Weaver D; Shepherd J; Wang J; Fan B; Mahmoudzadeh AP; Malkov S; Herschorn S; Brinton LA; Sherman ME; Gierach GL
    Breast Cancer Res; 2019 Jul; 21(1):81. PubMed ID: 31337427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients.
    Lønning PE; Helle SI; Johannessen DC; Adlercreutz H; Lien EA; Tally M; Ekse D; Fotsis T; Anker GB; Hall K
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):23-30. PubMed ID: 7534218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin growth factor (IGF) 1, IGF-binding proteins and ovarian cancer risk: A systematic review and meta-analysis.
    Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Pasupuleti V; Hernandez AV; Perez-Lopez FR
    Maturitas; 2016 Dec; 94():22-29. PubMed ID: 27823741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Rinaldi S; Landi S; Boillot C; Monnier S; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Ardanaz E; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Br J Cancer; 2006 Jan; 94(2):299-307. PubMed ID: 16404426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
    Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
    PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
    Eng-Wong J; Hursting SD; Venzon D; Perkins SN; Zujewski JA
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of treatment with onapristone on the IGF-system in breast cancer patients.
    Helle SI; Jonat W; Giurescu M; Ekse D; Holly JM; Lønning PE
    J Steroid Biochem Mol Biol; 1998 Aug; 66(3):159-63. PubMed ID: 9719450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
    Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
    Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
    McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D
    J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer.
    Holdaway IM; Mason BH; Lethaby AE; Singh V; Harvey VJ; Thompson PI; Evans BD
    ANZ J Surg; 2003 Nov; 73(11):905-8. PubMed ID: 14616567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer.
    Bruning PF; Van Doorn J; Bonfrèr JM; Van Noord PA; Korse CM; Linders TC; Hart AA
    Int J Cancer; 1995 Jul; 62(3):266-70. PubMed ID: 7543079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.